Related by context. All words. (Click for frequent words.) 77 acute coronary syndrome 71 acute coronary syndromes ACS 69 ST elevation myocardial 69 stable angina 69 unstable angina 68 acute myocardial infarction AMI 68 Acute Coronary Syndrome 68 segment elevation myocardial 67 multivessel disease 67 acute myocardial infarction 67 angina pectoris 66 ischemic cardiomyopathy 66 coronary intervention 66 myocardial infarction 65 infarction NSTEMI 65 atherothrombotic events 65 acute ischemic stroke 65 unstable angina UA 65 UA NSTEMI 65 percutaneous coronary intervention 65 infarction STEMI 65 coronary revascularization 65 STEMI ST 65 NYHA Class II 65 antiplatelet agents 64 thrombotic events 64 atherothrombotic disease 64 repeat revascularization 64 antithrombotics 64 myocardial infarction MI 64 antithrombotic therapy 64 ischemic complications 64 arterial thrombosis 64 risk stratification 64 coronary revascularization procedures 64 patients undergoing percutaneous 64 coronary artery disease 63 STEMI 63 severe aortic stenosis 63 postoperative atrial fibrillation 63 Acute Coronary Syndromes ACS 63 occlusive disease 63 thromboembolic 63 atrial fibrillation AF 63 unstable angina pectoris 63 revascularization procedures 63 thrombolytic therapy 63 ADHF 63 revascularization 63 tolvaptan 63 left ventricular dysfunction 63 rFVIIa 63 severe sepsis 63 decompensated heart failure 63 aspirin clopidogrel 63 ICD implantation 63 NATRECOR R 62 thrombolysis 62 cardiogenic shock 62 thrombolytic agents 62 MACCE 62 diabetic nephropathy 62 Acute Coronary Syndromes 62 thrombus aspiration 62 antiplatelet therapy 62 vWD 62 thromboembolic events 62 reperfusion therapy 62 XIENCE V PROMUS Stent 62 invasive candidiasis 62 recurrent ischemia 62 tirofiban 62 NATRECOR ® 62 non valvular atrial 62 STEMI patients 61 ischemic stroke 61 lipid lowering therapy 61 Thrombolysis 61 antihypertensive agents 61 antiplatelet medications 61 heparin induced thrombocytopenia 61 aldosterone antagonists 61 postoperative AF 61 engineered anticoagulant 61 preserved ejection fraction 61 myocardial infarctions 61 ticagrelor 61 atrial fibrillation 61 revascularisation 61 primary percutaneous coronary 61 eptifibatide 61 NSTE ACS 61 periprocedural 61 dyslipidaemia 61 LV dysfunction 61 bivalirudin 61 antiarrhythmic drug 61 AA Amyloidosis 61 silent ischemia 61 elevation acute coronary 61 hypercholesterolemia 61 carotid endarterectomy 61 carotid artery disease 61 ARIXTRA 61 Percutaneous Coronary Intervention 61 lipid lowering drugs 61 GP IIb IIIa inhibitors 61 failure ADHF 61 oral anticoagulation 61 systolic hypertension 61 Acute Myocardial Infarction 61 DVT PE 61 microvascular disease 61 atherothrombosis 61 Chronic Heart Failure 61 comorbid conditions 61 ischemic 61 thrombolytics 61 beta blocker therapy 60 fibrinolytic therapy 60 cardiac resynchronisation therapy 60 hyperkalemia 60 reinfarction 60 IIIa inhibitor 60 acute decompensated heart 60 myocardial ischemia 60 candidemia 60 VTE 60 macrovascular disease 60 invasive aspergillosis 60 AGGRASTAT ® tirofiban hydrochloride 60 colorectal liver metastases 60 statin therapy 60 AFib 60 CABG surgery 60 β blockers 60 Venous thromboembolism 60 Nesiritide 60 immunocompromised patients 60 renal insufficiency 60 VAPRISOL 60 mRCC 60 stenting 60 functional mitral regurgitation 60 vascular disease 60 Angiox R 60 coronary lesions 60 Coronary Artery Bypass Graft 60 thromboembolism 60 upper gastrointestinal bleeding 60 neovascular AMD 60 fondaparinux 60 aortic valve stenosis 60 infarction 60 glycoprotein IIb IIIa inhibitors 60 nonischemic 60 renal dysfunction 60 INTEGRILIN 60 tumor lysis syndrome 60 subclinical hypothyroidism 60 TAXUS Stent 59 anticoagulant therapy 59 Acute MI 59 atherosclerotic disease 59 dyslipidemia 59 post thrombotic syndrome 59 lipid lowering agents 59 diastolic heart 59 extrapyramidal symptoms 59 CABG 59 nesiritide 59 ATACAND 59 AGGRASTAT R tirofiban hydrochloride 59 pulmonary arterial hypertension PAH 59 PICSO ® 59 mixed dyslipidemia 59 aldosterone antagonist 59 antithrombotic agents 59 ximelagatran 59 thromboprophylaxis 59 neurogenic orthostatic hypotension 59 Erythropoietic therapies may 59 abciximab 59 infarctions 59 uncontrolled hypertension 59 HeFH 59 valvular disease 59 Ischemic 59 aortic stenosis 59 renal impairment 59 rosuvastatin 59 carcinoid tumors 59 coronary interventions 59 Val HeFT 59 ARCOXIA 59 STEMIs 59 familial hypercholesterolemia 59 DAPT 59 coronary stenting 59 unfractionated heparin 59 PAOD 59 antithrombotic therapies 59 carotid stenting 59 metastatic RCC 59 Valsartan 59 glitazones 59 carotid stenosis 59 TAXUS Express Stent 59 cardioembolic stroke 59 thrombotic complications 59 DU #b 59 thromboembolic complications 59 anticoagulation 58 onset atrial fibrillation 58 torsades de pointes 58 prostate cancer CaP 58 paroxysmal AF 58 infective endocarditis 58 carotid artery stenting CAS 58 anticoagulation therapy 58 lupus nephritis 58 patients undergoing CABG 58 NAVISTAR R 58 valsartan 58 cerebrovascular events 58 cytogenetic abnormalities 58 Neovascular AMD 58 paroxysmal atrial fibrillation 58 systemic fungal infections 58 thienopyridines 58 percutaneous intervention 58 revascularization procedure 58 antiplatelet drugs 58 lactic acidosis 58 antihypertensive therapy 58 ACUITY trial 58 carotid artery stenting 58 hepatorenal syndrome 58 progressive dyspnea 58 metastatic renal cell carcinoma 58 antiplatelet agent 58 CYPHER ® Stent 58 secondary hyperparathyroidism 58 Taxus Stent 58 arterial thromboembolic events 58 non metastatic osteosarcoma 58 recurrent VTE 58 atrial fibrillation AFib 58 chronic hemodialysis 58 terlipressin 58 olmesartan 58 interventional therapies 58 arrhythmias 58 myocardial infarction stroke 58 antithrombotic 58 EXJADE 58 paclitaxel eluting stents 58 Ischemic stroke 58 IV NSCLC 58 chronic myocardial ischemia 58 coronary disease 58 composite endpoint 58 diabetic retinopathy DR 58 postoperative pulmonary 58 undergoing angioplasty 58 angiotensin converting enzyme inhibitors 58 peripheral arterial disease 58 warfarin therapy 58 unstable angina chest 58 thromboembolic disease 58 VTE prophylaxis 58 TAXUS 58 venous thromboembolic events 58 diabetic gastroparesis 58 Candesartan 58 platelet reactivity 58 NSTEMI 58 venous thromboembolism VTE 58 Aortic stenosis 58 Unstable Angina 58 venous thromboembolism 58 TAXUS stent 58 fibromyalgia syndrome 58 coronary artery revascularization 58 anticoagulant warfarin 58 tenecteplase 58 concomitant medications 58 elective PCI 58 INCB# [003] 58 proliferative diabetic retinopathy 58 sirolimus stent 57 sirolimus eluting stent 57 diabetes mellitus 57 cirrhotic patients 57 hypercalcemia 57 chronic angina 57 dual antiplatelet therapy 57 hepatocellular carcinoma HCC 57 thrombophilia 57 systemic embolism 57 nosocomial pneumonia 57 hyperglycaemia 57 biventricular pacing 57 levosimendan 57 intravesical therapy 57 infusional 57 myocardial infarction ventricular fibrillation 57 isolated systolic hypertension 57 castrate resistant prostate cancer 57 definite stent thrombosis 57 oral antiplatelet therapy 57 intracerebral haemorrhage 57 hemorrhagic strokes 57 thrombotic diseases 57 thoracoscopic lobectomy 57 cerebrovascular accident 57 IPAH 57 cryptogenic stroke 57 Acute Myocardial Infarction AMI 57 renal denervation 57 venous thromboembolic disease 57 heterozygous FH 57 systemic lupus erythematosus 57 angiotensin converting enzyme inhibitor 57 TAVI 57 VIIBRYD 57 INTEGRILIN R 57 Acute Decompensated Heart Failure 57 systolic dysfunction 57 BENICAR HCT 57 refractory angina 57 Acute Ischemic Stroke 57 Angiomax 57 vitreoretinal disorders 57 cardiovascular morbidity 57 ZYVOX 57 cardiovascular hospitalization 57 microalbuminuria 57 dyslipidemic 57 recurrent stroke 57 adverse cytogenetics 57 bypass grafting 57 endarterectomy 57 ventricular tachycardia VT 57 vertebral compression fractures 57 advanced hepatocellular carcinoma 57 ST Elevation Myocardial 57 enoxaparin 57 Prehypertension 57 recurrent glioblastoma multiforme 57 symptomatic BPH 57 stable angina pectoris 57 cardiac resynchronization therapy 57 perioperative mortality 57 cSSSI 57 alteplase 57 TAVR 57 hypertension 57 COREG 57 atrial arrhythmias 57 angiotensin receptor blocker ARB 57 percutaneous coronary interventions 57 pulmonary hypertension PH 57 variceal bleeding 57 hypertensive patients 57 unfavorable cytogenetics 57 nonrandomized 57 symptomatic intracranial 57 ventricular fibrillation VF 57 symptomatic carotid stenosis 57 acute PAO 57 ventricular tachyarrhythmia 57 resynchronization therapy 57 candesartan 57 balloon valvuloplasty 57 palliation 57 Coronary Stent 57 hemodialysis patients 57 co morbidities 57 homozygous familial hypercholesterolemia 57 RE LY 57 Acute Myelogenous Leukemia AML 57 acute migraine 57 catheter occlusion 57 NYHA Class III 57 left ventricular systolic 57 vandetanib 57 intracranial bleeding 57 neovascular glaucoma 57 Vaprisol 57 Hepatocellular Carcinoma HCC 57 CYPHER Stent 57 von Willebrand disease 57 undergoing percutaneous coronary 57 clopidogrel 57 Hepatocellular Carcinoma 57 androgen deficiency 57 severe hypercholesterolemia 57 Embolic Protection Device 57 acute myocardial infarctions 57 surgical revascularization 57 coinfected patients 57 gastrointestinal GI motility disorders 57 angina 57 solid organ transplantation 57 paclitaxel eluting stent 57 Overactive Bladder 57 Cypher Stent 57 drug eluting stent implantation 57 ezetimibe simvastatin 57 arterial hypertension 57 eplerenone 57 TAXUS Liberte stent 57 cinacalcet 57 obstructive sleep apnea 57 Afib 57 Angiox 57 nonoperative 57 ACC AHA 57 elevated triglyceride levels 57 antiarrhythmic drugs 56 Benign Prostatic Hyperplasia BPH 56 Bucindolol 56 relapsing multiple sclerosis 56 Infarction 56 Angiox ® 56 complement inhibitor eculizumab 56 symptomatic hyponatremia 56 ticlopidine 56 coronary artery bypass grafting 56 refractory epilepsy 56 T2DM 56 resistant hypertension 56 ventricular dysfunction 56 hemorrhagic complications 56 metastatic malignant melanoma 56 aspirin heparin 56 pericardial effusion 56 preoperative chemotherapy 56 Tolvaptan 56 Thrombocytopenia 56 induced macular edema 56 TORISEL 56 recurrent DVT 56 Cardiac Resynchronization Therapy 56 renal tumors 56 acute STEMI 56 stenoses 56 hyperprolactinemia 56 death reinfarction 56 juvenile idiopathic arthritis JIA 56 Myelodysplastic Syndrome MDS 56 cerebral ischemia 56 cilostazol 56 Lactic acidosis 56 Lenalidomide 56 HBeAg negative 56 LHRH antagonists 56 SHPT 56 target vessel revascularization 56 venous insufficiency 56 Myocardial Infarction 56 prognostic variables 56 pancreatic adenocarcinoma 56 retinal vein occlusion 56 bradycardia 56 pulmonary arterial hypertension 56 nonfatal MI 56 TMP SMX 56 idiopathic pulmonary fibrosis IPF 56 postoperative delirium 56 thrombosis 56 MULTAQ 56 Diabetic Macular Edema 56 cardiomyopathies 56 PRADAXA 56 nicardipine 56 gefitinib Iressa 56 cerebral vasospasm 56 thrombocytopenic 56 alvimopan 56 stented 56 cardiovascular mortality 56 angiographic outcomes 56 acute coronary 56 prostate cancer CRPC 56 periprocedural MI 56 bosentan 56 XIENCE V demonstrated 56 elevation acute myocardial 56 beta blockers ACE inhibitors 56 endovascular therapy 56 open angle glaucoma 56 rhythm disturbances 56 Peripheral Arterial Disease 56 pheochromocytoma 56 mycophenolate mofetil 56 AGGRASTAT R 56 extracranial 56 geographic atrophy 56 percutaneous aortic valve 56 Ranolazine 56 cardiac dysfunction 56 atherosclerotic vascular disease 56 hypervascular tumors 56 mechanical thrombectomy 56 chronic periodontitis 56 hypercholesterolaemia 56 ischemic strokes 56 esophagogastric 56 restenosis 56 hypoparathyroidism 56 CRVO 56 VAD implantation 56 pancreatic insufficiency 56 antiplatelets 56 decitabine 56 VT VF 56 Patient Outcomes 56 ventricular arrhythmia 56 RE LY ® 56 mitral regurgitation 56 hyperphenylalaninemia HPA due 56 bucindolol 56 coronary atherosclerosis 56 Atypical Hemolytic Uremic Syndrome 56 mixed hyperlipidemia 56 sirolimus eluting stents 56 myeloproliferative neoplasms 56 azacitidine 56 stent restenosis 56 REOPRO 56 Desmoteplase 56 relapsed multiple myeloma 56 APTIVUS r 56 cerebral infarction 56 lupus renal disease 56 carotid artery blockage 56 LVEF 56 Events MACE 56 angioedema 56 endophthalmitis 56 TRITON TIMI 56 resuscitated cardiac arrest 56 Atacand 56 failure NYHA 56 LVSD 56 cardio metabolic 56 tachyarrhythmias 56 OPCAB 56 ruboxistaurin 56 platelet inhibitor 56 atypical Hemolytic Uremic Syndrome 56 intermittent claudication 56 comorbidities 56 Renal dysfunction 56 carotid stents 56 KETEK 56 pioglitazone 56 Natalizumab 56 ipsilateral stroke 56 carotid stent 56 thiazide diuretic 56 cangrelor 56 Doxil ® 56 bifurcation lesions 56 antiplatelet therapies 56 REG1 56 hyperuricemia 56 Idiopathic pulmonary fibrosis 56 antidiabetic drugs 56 Acute myocardial infarction 56 PSVT 56 Atrial Fibrillation 56 pacemaker implantation 56 dyslipidemias 56 T1DM 56 interstitial pneumonia 56 prophylactic therapy 55 dabigatran etexilate 55 nonfatal myocardial infarction MI 55 superficial bladder cancer 55 nephrotoxicity 55 ReoPro 55 chronic HCV infection 55 undergoing coronary artery 55 dopaminergic therapy 55 de novo lesions 55 Obstructive Sleep Apnea 55 Tekamlo 55 citalopram Celexa 55 transcatheter 55 nonfatal myocardial infarction 55 percutaneous interventions 55 coronary stent merged 55 drug eluting stent DES 55 intravascular 55 bypass graft CABG surgery 55 carotid endarterectomy CEA 55 milrinone 55 atherothrombotic 55 Multaq R 55 syncope 55 CYPHER R Stent 55 perindopril 55 Stent thrombosis 55 stent implantation 55 quetiapine 55 Fondaparinux 55 Trandolapril 55 everolimus eluting stent 55 acute myocardial infarction MI 55 Renal Cell Carcinoma RCC 55 Occlusive Disease 55 NOXAFIL 55 angiotensin receptor blockers ARBs 55 CTEPH 55 prospective multicenter study 55 venous thrombosis 55 chronic thromboembolic pulmonary 55 antihypertensives 55 candesartan cilexetil 55 Combination therapy 55 acutely decompensated heart 55 stratifying patients 55 NYHA 55 Clostridium difficile associated 55 non alcoholic steatohepatitis 55 intracerebral hemorrhage 55 thrombolytic agent 55 hyperlipidemia 55 Acute coronary syndromes 55 inotropes 55 GISSI HF 55 aHUS 55 intravenous diuretics 55 CYPHER R Sirolimus eluting 55 juvenile idiopathic arthritis 55 investigational therapies 55 Ventricular Tachycardia 55 arterial revascularization 55 follicular lymphoma FL 55 cardiovascular hospitalizations 55 oral anticoagulant 55 Non Alcoholic Fatty 55 death dissection perforation 55 posaconazole 55 overactive bladder syndrome 55 left ventricular hypertrophy 55 riociguat 55 amiodarone 55 HoFH 55 MI STEMI 55 lomitapide 55 Fibrillex TM 55 calcineurin inhibitors 55 chronic immune thrombocytopenic 55 ACTEMRA TM 55 atherogenic dyslipidemia 55 nephron sparing surgery 55 deferiprone 55 primary hypercholesterolemia 55 angina myocardial infarction 55 pseudobulbar affect PBA 55 HIV HCV coinfected 55 anti angiogenic agents 55 neointimal hyperplasia 55 myelofibrosis polycythemia vera 55 systemic immunosuppressive drugs 55 Brilique 55 rt PA 55 stage IIIB 55 recurrent GBM 55 ICD therapy 55 Stenting 55 TAXUS Liberte Stent 55 thalidomide Thalomid 55 muraglitazar 55 Warfarin Coumadin 55 EGFR inhibitors 55 TMS Therapy 55 dronedarone 55 angioplasty stenting 55 biliary tract cancer 55 tocilizumab 55 acne vulgaris 55 clevidipine 55 Aceon 55 herpetic keratitis 55 ARICEPT 55 noncardiac surgery 55 coronary vascular 55 familial amyloidotic polyneuropathy FAP 55 intracerebral hemorrhage ICH 55 diabetes mellitus DM 55 diabetic neuropathic pain 55 thienopyridine 55 PEGylated interferon beta 1a 55 primary hyperparathyroidism 55 adult chronic ITP 55 ZOLINZA 55 pathophysiologic 55 febrile neutropenia 55 partial onset seizures 55 proliferative retinopathy 55 severe renal impairment 55 peripheral arterial occlusive disease 55 xanthine oxidase inhibitor 55 Keppra R 55 TEAEs 55 retinal vein occlusion induced 55 warfarin 55 AIOD 55 eculizumab 55 undergoing coronary angiography 55 pulmonary embolism PE 55 binary restenosis 55 severe renal insufficiency 55 anticoagulants 55 Major Depressive Disorder MDD 55 tachyarrhythmia 55 symptomatic paroxysmal AF 55 refractory ischemia 55 myelodysplastic syndrome MDS 55 FRAGMIN 55 perioperative complications 55 Sycrest 55 hepatotoxicity 55 cardiovascular disease 55 PFO closure 55 efficacy evaluable 55 coronary angiography 55 receiving VELCADE 55 systemic corticosteroids 55 immunomodulation 55 TAXUS Liberté stent 55 Peripheral Artery Disease 55 antihypertensive drugs 55 relapsed SCLC 55 contrast induced nephropathy 55 Arixtra 55 leukotriene pathway 55 hemodynamically significant 55 unknown etiology 55 rheumatoid arthritis osteoarthritis ankylosing 55 Arrhythmias 55 Heart Failure 55 Decompensated Heart Failure 55 post herpetic neuralgia 55 CYPHER ® 55 aortic dissections 55 intracranial hemorrhage ICH 55 hepatocellular carcinoma 55 Pulmonary hypertension 55 VaD 55 stratify patients 55 acutely decompensated congestive heart 55 ramipril 55 efalizumab 55 calcineurin inhibitor 55 Amiodarone 55 immunosuppressive therapies 55 surrogate endpoint 55 macroalbuminuria 55 esophageal varices 55 Systemic Lupus Erythematosus SLE 55 hepatic insufficiency 55 lymphoma CTCL 55 Systemic Lupus Erythematosus 55 allogeneic HSCT 55 anticlotting drugs 55 Torisel 55 artery stenosis 55 paroxysmal nocturnal hemoglobinuria 55 LMWH 55 Rheumatoid Arthritis RA 55 refractory gout 55 bardoxolone methyl 55 nondiabetic patients 55 invasive fungal infections 55 transplantation HCT 54 Entereg R 54 β blocker 54 benign prostatic hypertrophy BPH 54 thrombotic 54 nonalcoholic steatohepatitis 54 TEMODAL 54 chronic HBV infection 54 infusional 5-FU/LV 54 veno occlusive disease 54 benazepril 54 prolonged QT interval 54 Coronary Artery Disease 54 postoperative morbidity 54 Unstable angina 54 relapsed refractory multiple myeloma 54 FFR guided treatment 54 COU AA 54 Torsades de Pointes 54 CABG procedures 54 irregular quivering 54 OSAHS 54 receptor tyrosine kinase inhibitor 54 HSCT 54 Clolar ® 54 cardiac insufficiency 54 osteoarthritis rheumatoid arthritis 54 reteplase 54 MERLIN TIMI 54 CANCIDAS 54 symptomatic VTE 54 mycosis fungoides 54 6R BH4 54 beta blocker 54 OAB symptoms 54 Neulasta ® 54 Major Depressive Disorder 54 dysfunction LVSD 54 ST Segment Elevation 54 metastatic neuroendocrine tumors 54 perioperatively 54 TAXUS Element Stent 54 transcatheter aortic valve implantation 54 coronary 54 Dyslipidemia 54 orthostatic hypotension 54 angiotensin receptor blockers 54 metaglidasen 54 SYNTAX trial 54 Uncontrolled hypertension 54 VTEs 54 NYHA class 54 valve implantation 54 intensive lipid lowering 54 micafungin 54 revascularizations 54 renal artery stenosis 54 potentially modifiable 54 systemic lupus erythematosus SLE 54 oral antidiabetic medication 54 COPD exacerbations 54 Hypotension 54 APTIVUS ritonavir 54 pulmonary hypertension 54 Allergic Rhinitis 54 transplantation HSCT 54 DES implantation 54 dilated cardiomyopathy DCM 54 Duloxetine 54 oral hypoglycemic agents 54 invasive coronary angiography 54 D dimer 54 Abciximab 54 recanalization 54 generalized seizures 54 visilizumab 54 Ischemia 54 urolithiasis 54 atrioventricular block 54 Pravastatin 54 Guideline Update 54 lipid disorders 54 undergoing CABG 54 AVAPRO 54 induce orthostatic hypotension 54 malignant neoplasms 54 stent placement 54 acute exacerbations 54 CMV disease 54 Fibrin Pad 54 Octreolin 54 erythematosus SLE 54 fatal myocardial infarction 54 overactive bladder OAB 54 coagulopathy 54 transient ischemic attack 54 moderate renal impairment 54 hypertriglyceridemia 54 Myocardial Infarction Study 54 Helicobacter pylori eradication 54 DEFINITY ® 54 sorafenib Nexavar 54 reperfusion injury 54 subclinical atherosclerosis 54 intracranial stenosis 54 Angioedema 54 ADVEXIN therapy 54 elevation myocardial infarction 54 rivaroxaban 54 carcinoid 54 morbidity mortality 54 occlusion CRVO 54 drug eluting coronary stents 54 overt nephropathy 54 Cetrorelix 54 cell lymphoma CTCL 54 Dabigatran 54 renal anemia 54 morphometric vertebral fractures 54 cardiovascular ischemic 54 renal transplantation 54 embolic stroke 54 onset diabetes mellitus 54 coronary blockages 54 liver transplantation 54 PNH patients 54 Idiopathic Pulmonary Fibrosis 54 androgen deprivation 54 ivabradine 54 ICD implants 54 oral anticoagulants 54 recurrent venous thromboembolism 54 chronic idiopathic thrombocytopenic purpura 54 paroxetine Paxil 54 systemic lupus erythematosus psoriasis 54 metastatic malignant 54 gastric varices 54 angina chest 54 choroidal neovascularization 54 Clopidogrel 54 alpha blocker 54 idiopathic thrombocytopenic purpura 54 HES CEL 54 statins 54 systemic corticosteroid 54 cytoreductive nephrectomy 54 recurrent myocardial infarction 54 kidney transplant recipients 54 intracoronary 54 InterStim Therapy 54 refractory AML 54 elotuzumab 54 acute myelogenous leukemia AML 54 myopathy rhabdomyolysis 54 cerebrovascular disease 54 Pioglitazone 54 hypoxemia 54 postoperative ileus POI 54 sJIA 54 liposomal amphotericin B 54 dose atorvastatin 54 LEUKINE 54 carotid artery stent 54 carcinoid syndrome 54 Severe Primary IGFD 54 ventricular arrhythmias 54 conventional antipsychotics 54 noninfectious uveitis 54 deep venous thromboses 54 Acute renal failure 54 nonmetastatic prostate cancer 54 malignant pleural mesothelioma 54 AGGRASTAT ® 54 phase IIb clinical 54 PROactive study 54 Exacerbations 54 rosuvastatin #mg 54 FROVA 54 lymphadenectomy 54 CYP#C# [001] 54 eritoran 54 PROMUS 54 Stent System 54 hyperplasia BPH 54 clinically localized prostate 54 chemoradiotherapy 54 subependymal giant cell 54 esophageal candidiasis 54 antihypertensive medications 54 Mild Cognitive Impairment 54 leukemia AML 54 insulin detemir 54 hypotension 54 ACE inhibitors 54 clopidogrel Plavix 54 Retisert TM 54 antiplatelet medication 54 fibrinolytic 54 ischemia driven 54 recurrent acute pancreatitis 54 Ventricular tachycardia 54 neovascular 54 minimally symptomatic 54 Inhaled corticosteroids 54 chlorambucil 54 sirolimus 54 percutaneous transluminal coronary angioplasty 54 optic neuropathy 54 Perforomist ™ Inhalation Solution 54 ribavirin RBV 54 lumbar spinal stenosis 54 kidney urologic 54 adjuvant therapy 54 PEG INTRON 54 interferon beta therapy 54 PEGINTRON TM 54 colon perforation 54 valvular heart 54 cardiac